Drug failed in human testing according to there filing which is why the stock fell. They have to go back and redo the initial testing and get FDA approval for human testing again. Even though the drug may be effected this will take time and financing which they don’t have hence the issue of new shares. Now a serious RS maybe near :(
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.